US FDA issues warning letter for Torrent Pharma’s Indrad plant in Gujarat

- This action follows the earlier intimation received· from US FDA in August 2019, wherein the agency had classified its inspection as 'Official Action Indicated'
- The regulator had also said that the company did not have written procedures for production of medicines